| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $25.7M | -46.8% |
| SG&A Expense | $9.6M | -19.3% |
| Operating Income | -$35.3M | +41.3% |
| Income Tax | $0 | -100.0% |
| Net Income | -$33.8M | +39.4% |
| EPS (Basic) | -$0.56 | +40.4% |
| EPS (Diluted) | -$0.56 | +40.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.0M | +28.5% |
| Short-term Investments | $46.6M | +0.0% |
| Current Assets | $71.8M | -31.0% |
| Total Assets | $72.1M | -31.1% |
| Current Liabilities | $27.8M | +49.5% |
| Long-term Debt | $15.3M | +0.0% |
| Total Liabilities | $27.8M | -17.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.3M | +22.8% |
| Investing Cash Flow | $47.7M | +206.3% |
| Financing Cash Flow | $1.1M | +755.4% |
| Stockholders' Equity |
| $44.3M |
| -37.7% |